Tbx20 functions as an important regulator of estrogen-mediated cardiomyocyte protection during oxidative stress

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3704-3714

  Shen, Tao ^a   Yang, Chongqing ^a   Ding, Ling ^a,b   Zhu, Yuping ^a   Ruan, Yang ^a   Cheng, Hongqiang ^c   Qin, Weiwei ^a,b   Huang, Xiuqing ^a   Zhang, Hangxiang ^a   Man, Yong ^a   Liu, Dongge ^a   Wang, Shu ^a   Bian, Yunfei ^b   Xiao, Chuanshi ^b   Zhao, Yongxiang ^d   Li, Jian ^a  

^a BEIJING HOSPITAL   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

17 estradiol; Apoptosis; Esrra; Heart failure; Oxidative stress; Tbx20

Indexed keywords

CASPASE 3; ESTRADIOL; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX20; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; AUTOPSY; CARDIOMYOPATHY; CELL STRAIN; CELL STRAIN H9C2; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ESRRA GENE; ESTROGEN ACTIVITY; FEMALE; GENE; GENE EXPRESSION REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION;

17Β-ESTRADIOL; APOPTOSIS; ESRRA; HEART FAILURE; OXIDATIVE STRESS; TBX20;

AGED; AGED, 80 AND OVER; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; ESTROGENS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; T-BOX DOMAIN PROTEINS;

EID: 84886242921     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.018     Document Type: Article

References (46)

1. J.C. Kiefer The Tbx-files: the truth is out there Dev Dyn 231 1 2004 232 236
2. C.L. Cai, W. Zhou, and L. Yang T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis Development 132 10 2005 2475 2487
3. A. Iio, M. Koide, K. Hidaka, and T. Morisaki Expression pattern of novel chick T-box gene, Tbx20 Dev Genes Evol 211 11 2001 559 562
4. F. Kraus, B. Haenig, and A. Kispert Cloning and expression analysis of the mouse T-box gene tbx20 Mech Dev 100 1 2001 87 91
5. J.K. Takeuchi, M. Mileikovskaia, and K. Koshiba-Takeuchi Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development Development 132 10 2005 2463 2474
6. M.K. Singh, V.M. Christoffels, and J.M. Dias Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2 Development 132 12 2005 2697 2707
7. F.A. Stennard, M.W. Costa, and D.A. Elliott Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart Dev Biol 262 2 2003 206 224
8. E.P. Kirk, M. Sunde, and M.W. Costa Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy Am J Hum Genet 81 2 2007 280 291
9. T. Shen, I. Aneas, and N. Sakabe Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function J Clin Invest 121 12 2011 4640 4654
10. D.D. Brown, S.N. Martz, and O. Binder Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis Development 132 3 2005 553 563
11. A. Pfeufer, C. van Noord, and K.D. Marciante Genome-wide association study of PR interval Nat Genet 42 2 2010 153 159
12. Q.Y. Li, R.A. Newbury-Ecob, and J.A. Terrett Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family Nat Genet 15 1 1997 21 29
13. C.T. Basson, D.R. Bachinsky, and R.C. Lin Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome Nat Genet 15 1 1997 30 35
14. C.E. Gleason, C.M. Carlsson, S. Johnson, C. Atwood, and S. Asthana Clinical pharmacology and differential cognitive efficacy of estrogen preparations Ann N Y Acad Sci 1052 2005 93 115
15. M.R. Dent, P.S. Tappia, and N.S. Dhalla Gender differences in apoptotic signaling in heart failure due to volume overload Apoptosis 15 4 2010 499 510
16. C.J. Liu, J.F. Lo, and C.H. Kuo Akt mediates 17beta-estradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necresis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway J Cell Mol Med 13 9B 2009 3655 3667
17. R.D. Patten, and R.H. Karas Estrogen replacement and cardiomyocyte protection Trends Cardiovasc Med 16 3 2006 69 75
18. T. Pelzer, M. Neumann, T. de Jager, V. Jazbutyte, and L. Neyses Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta Biochem Biophys Res Commun 286 5 2001 1153 1157
19. A.S. Pechenino, L. Lin, and F.N. Mbai Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation Physiol Genomics 43 18 2011 1065 1073
20. J.K. Kim, A. Pedram, M. Razandi, and E.R. Levin Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms J Biol Chem 281 10 2006 6760 6767
21. M. Satoh, C.M. Matter, and H. Ogita Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen Circulation 115 25 2007 3197 3204
22. M. Wang, Y. Wang, and B. Weil Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia Am J Physiol Regul Integr Comp Physiol 296 4 2009 R972 R978
23. Y. Wang, Q. Wang, and Y. Zhao Protective effects of estrogen against reperfusion arrhythmias following severe myocardial ischemia in rats Circ J 74 4 2010 634 643
24. +/ calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice J Clin Invest 119 5 2009 1230 1240
25. Y. Kamada, S. Kiso, and Y. Yoshida Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet Am J Physiol Gastrointest Liver Physiol 301 6 2011 G1031 G1043
26. B.H. Kim, Y.S. Won, and D.Y. Kim Signal crosstalk between estrogen and peroxisome proliferator-activated receptor alpha on adiposity BMB Rep 42 2 2009 91 95
27. T. Shen, M. Zheng, and C. Cao Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis J Biol Chem 282 32 2007 23354 23361
28. R. Querejeta, N. Varo, and B. Lopez Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease Circulation 101 14 2000 1729 1735
29. S.M. Belcher, Y. Chen, S. Yan, and H.S. Wang Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17beta-estradiol and the environmental endocrine disruptor bisphenol A Endocrinology 153 2 2012 712 720
30. H. Liu, A. Pedram, and J.K. Kim Oestrogen prevents cardiomyocyte apoptosis by suppressing p38alpha-mediated activation of p53 and by down-regulating p53 inhibition on p38beta Cardiovasc Res 89 1 2011 119 128
31. C. Ginghina, I. Craciunescu, and V. Iorga Therapeutical perspectives for apoptosis modulation in cardiovascular disease Rom J Intern Med 44 3 2006 213 222
32. E.E. Creemers, and Y.M. Pinto Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart Cardiovasc Res 89 2 Feb. 1, 2011 265 272
33. J. Diez, B. Lopez, A. Gonzalez, and R. Querejeta Clinical aspects of hypertensive myocardial fibrosis Curr Opin Cardiol 16 6 2001 328 335
34. B.S. Burlew, and K.T. Weber Connective tissue and the heart. Functional significance and regulatory mechanisms Cardiol Clin 18 3 2000 435 442
35. G.W. Dorn Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling Cardiovasc Res 81 3 2009 465 473
36. C.A. Vigliano, P.M. Cabeza Meckert, and M. Diez Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure J Am Coll Cardiol 57 14 2011 1523 1531
37. M. Pierdominici, E. Ortona, F. Franconi, M. Caprio, E. Straface, and W. Malorni Gender specific aspects of cell death in the cardiovascular system Curr Pharm Des 17 11 2011 1046 1055
38. D. Fliegner, C. Schubert, and A. Penkalla Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload Am J Physiol Regul Integr Comp Physiol 298 6 2010 R1597 R1606
39. X. Wang, L. Cui, and J. Joseph Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress J Mol Cell Cardiol Mar 52 3 2012 753 760
40. Q. Xu, A. Dalic, and L. Fang Myocardial oxidative stress contributes to transgenic beta(2)-adrenoceptor activation-induced cardiomyopathy and heart failure Br J Pharmacol 162 5 2011 1012 1028
41. E.M. Redout, M.J. Wagner, and M.J. Zuidwijk Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species Cardiovasc Res 75 4 2007 770 781
42. X. Palomer, D. Varez-Guardia, and R. Rodriguez-Calvo TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model Cardiovasc Res 81 4 2009 703 712
43. J. Li, M. Wu, and L. Que 17beta-estradiol attenuates cardiac dysfunction and decreases NF-kappaB binding activity in mechanically stretched rat hearts Steroids 73 7 2008 720 726
44. J.T. Hsu, W.H. Kan, and Y.C. Hsieh Mechanism of estrogen-mediated improvement in cardiac function after trauma-hemorrhage: p38-dependent normalization of cardiac Akt phosphorylation and glycogen levels Shock 30 4 2008 372 378
45. J. Schilling, and D.P. Kelly The PGC-1 cascade as a therapeutic target for heart failure J Mol Cell Cardiol 51 4 2011 578 583
46. M. Ichida, S. Nemoto, and T. Finkel Identification of a specific molecular repressor of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1alpha) J Biol Chem 277 52 2002 50991 50995